Clinical Trials Browser

Phase 2 × relatlimab × Tumor-Agnostic × Clear all

NCT05347212 2025-10-10

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Phase 2 Active not recruiting

Carcinoma